Recursion Pharmaceuticals, Inc. (RXRX)
3.80
+0.13
(+3.54%)
USD |
NASDAQ |
Jul 02, 16:00
3.795
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Price to Book Value : 1.968 for July 2, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| July 02, 2026 | 1.968 |
| July 01, 2026 | 1.900 |
| June 30, 2026 | 1.900 |
| June 29, 2026 | 1.911 |
| June 26, 2026 | 1.823 |
| June 25, 2026 | 1.730 |
| June 24, 2026 | 1.672 |
| June 23, 2026 | 1.636 |
| June 22, 2026 | 1.647 |
| June 18, 2026 | 1.672 |
| June 17, 2026 | 1.610 |
| June 16, 2026 | 1.647 |
| June 15, 2026 | 1.704 |
| June 12, 2026 | 1.631 |
| June 11, 2026 | 1.631 |
| June 10, 2026 | 1.574 |
| June 09, 2026 | 1.667 |
| June 08, 2026 | 1.719 |
| June 05, 2026 | 1.716 |
| June 04, 2026 | 1.968 |
| June 03, 2026 | 1.797 |
| June 02, 2026 | 1.869 |
| June 01, 2026 | 1.962 |
| May 29, 2026 | 1.859 |
| May 28, 2026 | 1.781 |
| Date | Value |
|---|---|
| May 27, 2026 | 1.641 |
| May 26, 2026 | 1.538 |
| May 22, 2026 | 1.559 |
| May 21, 2026 | 1.610 |
| May 20, 2026 | 1.533 |
| May 19, 2026 | 1.476 |
| May 18, 2026 | 1.496 |
| May 15, 2026 | 1.517 |
| May 14, 2026 | 1.574 |
| May 13, 2026 | 1.579 |
| May 12, 2026 | 1.631 |
| May 11, 2026 | 1.688 |
| May 08, 2026 | 1.719 |
| May 07, 2026 | 1.693 |
| May 06, 2026 | 1.776 |
| May 05, 2026 | 1.745 |
| May 04, 2026 | 1.823 |
| May 01, 2026 | 1.755 |
| April 30, 2026 | 1.792 |
| April 29, 2026 | 1.709 |
| April 28, 2026 | 1.766 |
| April 27, 2026 | 1.802 |
| April 24, 2026 | 1.818 |
| April 23, 2026 | 1.812 |
| April 22, 2026 | 1.931 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Stoke Therapeutics, Inc. | 5.154 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 21.97 |
| Anika Therapeutics, Inc. | 1.532 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 27.47 |
| Price | 3.80 |
| Earnings Yield | -31.64% |
| Market Cap | 2.016B |